Back to ARNA Stock Lookup

Arena Pharma (ARNA) – Company Press Releases

Nov 25, 2014 08:00 AM Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Related Compounds
Nov 24, 2014 08:00 AM Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference
Nov 13, 2014 08:00 AM Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference
Nov 6, 2014 08:00 AM Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases
Nov 5, 2014 08:00 AM Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference
Nov 3, 2014 06:45 AM Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results
Nov 3, 2014 06:30 AM Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Cessation
Oct 31, 2014 08:00 AM Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting
Oct 31, 2014 08:00 AM Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting
Oct 28, 2014 06:20 PM Eisai and Arena Pharmaceuticals Report Results of an Investigational Pilot Study of Coadministration of Lorcaserin HCl and Phentermine HCl
Oct 27, 2014 08:00 AM Arena Pharmaceuticals Announces Third Quarter 2014 Conference Call and Webcast on Monday, November 3
Oct 13, 2014 08:00 AM Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at the American College of Clinical Pharmacy Annual Meeting
Oct 10, 2014 11:36 AM Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 Clinical Trial Analysis of BELVIQ® (lorcaserin HCl) CIV in Postgraduate Medicine

Back to ARNA Stock Lookup